Stiolto Respimat (tiotropium bromide and olodaterol) is a brand-name inhalation spray prescribed for chronic obstructive pulmonary disease (COPD) in adults. Stiolto Respimat can cause side effects ...
Inhaled anaesthetic agents are estimated to account for up to 3% of total national healthcare greenhouse gas emissions in high income countries, and between 0.01% and 0.1% of greenhouse gas emissions ...
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler ...